Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study.
Saved in:
| Title: | Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study. |
|---|---|
| Authors: | Saberi Hosnijeh F; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands. Electronic address: f.saberihosnijeh@erasmusmc.nl., van der Straten L; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands., Kater AP; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands., van Oers MHJ; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands., Posthuma WFM; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Chamuleau MED; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands., Bellido M; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Doorduijn JK; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., van Gelder M; Department of Hematology, University Medical Center, Maastricht, The Netherlands., Hoogendoorn M; Department of Internal Medicine, Medical Center, Leeuwarden, The Netherlands., de Boer F; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands., Te Raa GD; Department of Internal Medicine, Gelderland Valley Hospital, Ede, The Netherlands., Kerst JM; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Marijt EWA; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Raymakers RAP; Department of Hematology, University Medical Center, Utrecht, The Netherlands., Koene HR; Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands., Schaafsma MR; Department of Hematology, Medical Spectrum Twente, Enschede, The Netherlands., Dobber JA; Laboratory Special Hematology, Academic Medical Center, Amsterdam, The Netherlands., Tonino SH; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands., Kersting SS; Department of Hematology, Haga Hospital, The Hague, The Netherlands., Langerak AW; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands., Levin MD; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands. |
| Source: | Experimental hematology [Exp Hematol] 2020 Sep; Vol. 89, pp. 55-60.e6. Date of Electronic Publication: 2020 Aug 08. |
| Publication Type: | Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article |
| Journal Info: | Publisher: Elsevier Science Inc Country of Publication: Netherlands NLM ID: 0402313 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-2399 (Electronic) Linking ISSN: 0301472X NLM ISO Abbreviation: Exp Hematol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32781097 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Saberi+Hosnijeh+F%22">Saberi Hosnijeh F</searchLink>; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Institute for Risk Assessment Sciences, Division of Environmental Epidemiology, Utrecht University, Utrecht, The Netherlands. Electronic address: f.saberihosnijeh@erasmusmc.nl.<br /><searchLink fieldCode="AU" term="%22van+der+Straten+L%22">van der Straten L</searchLink>; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kater+AP%22">Kater AP</searchLink>; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Oers+MHJ%22">van Oers MHJ</searchLink>; Department of Hematology and Lymphoma and Myeloma Center Amsterdam, Academic Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Posthuma+WFM%22">Posthuma WFM</searchLink>; Department of Internal Medicine, Reinier de Graaf Hospital, Delft, The Netherlands; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Chamuleau+MED%22">Chamuleau MED</searchLink>; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bellido+M%22">Bellido M</searchLink>; Department of Hematology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Doorduijn+JK%22">Doorduijn JK</searchLink>; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22van+Gelder+M%22">van Gelder M</searchLink>; Department of Hematology, University Medical Center, Maastricht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Hoogendoorn+M%22">Hoogendoorn M</searchLink>; Department of Internal Medicine, Medical Center, Leeuwarden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Boer+F%22">de Boer F</searchLink>; Department of Internal Medicine, Ikazia Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Te+Raa+GD%22">Te Raa GD</searchLink>; Department of Internal Medicine, Gelderland Valley Hospital, Ede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kerst+JM%22">Kerst JM</searchLink>; Department of Medical Oncology, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Marijt+EWA%22">Marijt EWA</searchLink>; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Raymakers+RAP%22">Raymakers RAP</searchLink>; Department of Hematology, University Medical Center, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koene+HR%22">Koene HR</searchLink>; Department of Internal Medicine, St Antonius Hospital, Nieuwegein, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Schaafsma+MR%22">Schaafsma MR</searchLink>; Department of Hematology, Medical Spectrum Twente, Enschede, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dobber+JA%22">Dobber JA</searchLink>; Laboratory Special Hematology, Academic Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Tonino+SH%22">Tonino SH</searchLink>; Department of Hematology, Academic Medical Center, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersting+SS%22">Kersting SS</searchLink>; Department of Hematology, Haga Hospital, The Hague, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Langerak+AW%22">Langerak AW</searchLink>; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Levin+MD%22">Levin MD</searchLink>; Department of Internal Medicine, Albert Schweitzer Hospital, Dordrecht, The Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220402313%22">Experimental hematology</searchLink> [Exp Hematol] 2020 Sep; Vol. 89, pp. 55-60.e6. <i>Date of Electronic Publication: </i>2020 Aug 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science+Inc%22">Elsevier Science Inc </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>0402313 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1873-2399 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220301472X%22">0301472X </searchLink><i>NLM ISO Abbreviation: </i>Exp Hematol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32781097 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.exphem.2020.08.002 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 55 Titles: – TitleFull: Proteomic markers with prognostic impact on outcome of chronic lymphocytic leukemia patients under chemo-immunotherapy: results from the HOVON 109 study. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Saberi Hosnijeh F – PersonEntity: Name: NameFull: van der Straten L – PersonEntity: Name: NameFull: Kater AP – PersonEntity: Name: NameFull: van Oers MHJ – PersonEntity: Name: NameFull: Posthuma WFM – PersonEntity: Name: NameFull: Chamuleau MED – PersonEntity: Name: NameFull: Bellido M – PersonEntity: Name: NameFull: Doorduijn JK – PersonEntity: Name: NameFull: van Gelder M – PersonEntity: Name: NameFull: Hoogendoorn M – PersonEntity: Name: NameFull: de Boer F – PersonEntity: Name: NameFull: Te Raa GD – PersonEntity: Name: NameFull: Kerst JM – PersonEntity: Name: NameFull: Marijt EWA – PersonEntity: Name: NameFull: Raymakers RAP – PersonEntity: Name: NameFull: Koene HR – PersonEntity: Name: NameFull: Schaafsma MR – PersonEntity: Name: NameFull: Dobber JA – PersonEntity: Name: NameFull: Tonino SH – PersonEntity: Name: NameFull: Kersting SS – PersonEntity: Name: NameFull: Langerak AW – PersonEntity: Name: NameFull: Levin MD IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 09 Text: 2020 Sep Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1873-2399 Numbering: – Type: volume Value: 89 Titles: – TitleFull: Experimental hematology Type: main |
| ResultId | 1 |
